FENC FY 2022 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

FENCFennec Pharmaceuticals Inc.

$220M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$1M94.4% margin

Operating Income

-$22M-1471.6% margin

Net Income

-$23M-1544.9% margin

EPS (Diluted)

$-0.95

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$27M

Total Liabilities

$30M

Stockholders' Equity

-$3M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$22M	-$17M	-27.1%
Net Income	-$23M	-$17M	-32.5%